Navigation Links
263 Regulatory Professionals Achieve RAC Certification
Date:9/4/2009

ROCKVILLE, Md., Sept. 4 /PRNewswire-USNewswire/ -- The Regulatory Affairs Professionals Society (RAPS) has announced that 263 regulatory professionals achieved Regulatory Affairs Certification (RAC) during the most recent exam period. The RAC credential is administered by RAPS and is the only certification specifically for regulatory professionals in the healthcare product sector.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090403/DC89286LOGO )

Regulatory professionals are involved in every stage of developing and bringing safe and effective drugs, medical devices, biotechnology and other healthcare products to market. More than 5,000 individuals around the world have earned the RAC. A full list of the new class of 263 and all current RACs is online at RAPS.org/rac, along with registration information for the upcoming exam cycle. The deadline to register for the October/November RAC exam cycle is 8 September.

"Regulatory expertise has become increasingly important and highly valued by companies and organizations in the healthcare product sector," said RAPS Executive Director Sherry Keramidas, PhD, CAE. "Having the RAC credential demonstrates to employers, regulators and others that this person not only has the knowledge of regulations and regulatory processes but also the critical thinking skills to apply that knowledge to a range of scenarios."

The RAC credential denotes commitment to excellence, pursuit of knowledge and career advancement. RAC-credentialed professionals are among the current and rising leaders in the regulatory profession. They work in all parts of the world and in many settings, including industry, government and academic organizations. RAPS' research has shown that holding an RAC is correlated to greater compensation among professionals in entry- to mid-level positions and that the proportion of RAC-credentialed professionals increases steadily at higher levels.

Four different RAC certifications are available: RAC (US) covering US regulations, RAC (EU) for European regulations, RAC (CAN) for Canadian regulations and RAC General Scope (GS), covering general regulatory knowledge and international standards. The credential initially is earned by passing one of the four RAC examinations and maintained through continuing professional development.

Many RAC-credentialed professionals will be in attendance at the 2009 RAPS Annual Conference & Exhibition at the Pennsylvania Convention Center in Philadelphia, 13-16 September.

About RAPS

The Regulatory Affairs Professionals Society (RAPS) is an international membership organization of regulatory professionals in the rapidly growing medical device, pharmaceutical and biotechnology sectors. Regulatory professionals play vital roles in making better healthcare products possible. They work throughout the healthcare product lifecycle, ensuring these products are safe and effective, while driving organizational strategy and sound decision-making. RAPS supports these individuals and the regulatory profession by providing education and training, Regulatory Affairs Certification (RAC), professional standards, research, knowledge-sharing, publications, networking, career development opportunities and other valuable resources; and is committed to helping its members continually develop the knowledge and skills they need to excel. RAPS is headquartered near Washington, DC, with offices in Brussels and Tokyo. RAPS.org


'/>"/>
SOURCE Regulatory Affairs Professionals Society (RAPS)
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Medicago receives regulatory approval to begin human clinical testing with its avian flu pandemic vaccine
2. SyntheMed Receives Russian Regulatory Approval for REPEL-CV(TM)
3. Wyeth Provides Regulatory Update on Prevnar 13* in the United States
4. Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres
5. PharmAthenes 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review
6. Johnson & Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology
7. NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)
8. SyntheMed Receives Australian Regulatory Approval for REPEL-CV(R)
9. Agendia Supports Genentechs Citizens Petition Urging FDA to Hold In-Vitro Diagnostic Tests to One Set of Scientific and Regulatory Standards
10. PAREXEL Consulting Experts To Present Insights Into Achieving Regulatory Approval at the 2009 BIO International Convention
11. DuPont Receives Canadian Regulatory Approval for High Oleic Soybean Trait
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... WEST LAFAYETTE, Indiana (PRWEB) , ... ... ... a division of Albany Molecular Research Inc. has further extended its industry ... sector. This service offers state-of-the-art cGMP techniques and methods for the ...
(Date:2/15/2017)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced financial ... full year ended December 31, 2016. ... we continued to demonstrate strong growth in our ... said Mihael H. Polymeropoulos, M.D., Vanda,s President and ... 2017 milestones underscores Vanda,s commitment to bringing important ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):